Hosted on MSN9d
Boston Scientific sees success in PFA device trialUS healthtech giant Boston Scientific’s pulmonary vein isolation (PVI) device trial has met its primary endpoint in patients ...
US healthtech giant Boston Scientific’s pulmonary vein isolation (PVI) device trial has met its primary endpoint in patients with paroxysmal atrial fibrillation (AF) as the company looks to ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback